Intellectual Property

  • August 07, 2025

    Settlement Ends Lashify Patent Case After Fed. Circ. Ruling

    Eyelash extension maker Lashify and a company it accused of patent infringement have reached a settlement, according to a Thursday filing at the U.S. International Trade Commission, after the Federal Circuit used the case to relax rules on filing suits at the ITC.

  • August 07, 2025

    9th Circ. Says Attys Can't Get $920K Fees For $8K Trial Win

    The Ninth Circuit affirmed a lower court's decision Thursday to deny a request of over $920,000 in attorney fees from the creator of two strategic problem-solving charts following her jury trial win of $8,000 in a copyright infringement case, saying the district court property articulated the reasons for the denial.

  • August 07, 2025

    Fintiv Says Apple's 'Trojan Horse' Stole Mobile Wallet Tech

    Fintiv Inc. upped the ante Wednesday in its mobile wallet technology litigation against Apple Inc., accusing it in a new lawsuit of "theft and racketeering of monumental proportions" just days after a Texas federal judge called off a looming patent trial between the companies.

  • August 07, 2025

    Music Publishers Denied Anthropic User Info In AI Case

    A California federal judge on Thursday denied a request from music publishers for the names of people who used Anthropic PBC's generative text tool Claude to get copyrighted lyrics, saying she was not persuaded that production of personal third-party user information was needed for the infringement litigation.

  • August 07, 2025

    PTAB Knocks Out Nike Patent From $355K Trial Victory

    A Nike footwear manufacturing patent at the heart of a $355,450 damages verdict in an infringement case against athletic apparel maker Lululemon is invalid, the Patent Trial and Appeal Board has found.

  • August 07, 2025

    NFL, Hall Of Fame Sued Over 'Gold Jacket' Trademark

    The estate of the man who created the iconic Gold Jacket presented to NFL's Pro Football Hall of Fame inductees has sued the organization, the league and others in Florida federal court over allegedly infringing the trademark and trade dress of the blazer and other alumni-related marks.

  • August 07, 2025

    USPTO's Chief Information Officer Leaves Agency

    The U.S. Patent and Trademark Office's chief information officer is departing the agency for a job in the private sector, and the deputy CIO is stepping up to fill the position, a spokesperson confirmed to Law360 on Thursday.

  • August 07, 2025

    BioNTech's Acquisition Of CureVac Ends COVID Vax Case

    CureVac's case alleging Pfizer and BioNTech infringed patents related to messenger RNA technology is set to be dismissed after BioNTech announced in June that it would be acquiring CureVac, canceling what would have been the first-ever trial over COVID-19 vaccine patents in the U.S.

  • August 07, 2025

    'Cardiac Pack' IP Suit Is Decades Too Late, NC Judge Says

    A North Carolina state court on Thursday dismissed a lawsuit brought by 12 members of North Carolina State University's 1983 "Cardiac Pack" basketball team alleging that the NCAA unduly profited from their name, image and likeness by rebroadcasting footage from their national championship run.

  • August 07, 2025

    Connecticut Litigation Highlights In The 1st Half Of 2025

    Two separate royalty disputes — one $90 million, the other $4 million — involving two giants in the alcoholic beverages market are among the top corporate cases that crossed Connecticut court dockets in the first half of 2025.

  • August 07, 2025

    5th Circ. Denies Fees For Activision After Call Of Duty TM Win

    The Fifth Circuit has found a Texas federal judge did not abuse his discretion when he denied video game publisher Activision's request for attorney fees after defeating a trademark infringement suit brought by a former professional wrestler.

  • August 07, 2025

    Novartis Faces $291M Trade Secrets Suit From Hedge Fund

    A hedge fund on Thursday accused Novartis, a former investment executive and the executive's longtime friend and business partner of scheming to steal its "innovative hedge fund strategy" after an investment deal between the biotech giant and the hedge fund went south. 

  • August 07, 2025

    PTAB Ordered To Explain Invalidation Of Car Inspection Patent

    The Federal Circuit on Thursday faulted the Patent Trial and Appeal Board for invalidating claims in a patent for a radiation-based vehicle inspection system, saying the board's "conclusory assertions and lack of explanation or reasoning" prevent the appeals court from giving its decision a meaningful review.

  • August 07, 2025

    Bacardi Can't Stymie Rum TM Renewal, USPTO Tells 4th Circ.

    The U.S. Patent and Trademark Office told the Fourth Circuit its former director was right to renew a Cuban company's expired trademark registration for Havana Club rum after the company got retroactive approval to pay the registration fee, even if beverage giant Bacardi said it was too late.

  • August 07, 2025

    CoStar Asks Full 9th Circ. To Revisit Antitrust Ruling For Rival

    Commercial real estate information company CoStar Group Inc. and a subsidiary are urging the Ninth Circuit to reconsider its ruling reviving antitrust counterclaims lodged by rival Commercial Real Estate Exchange Inc., which CoStar has accused in a suit of stealing property listing data and copyrighted photos.

  • August 07, 2025

    Housing Advocates Say Opponents Stole Name For PAC

    A housing advocacy nonprofit in the Boston suburb of Newton say that opponents of a zoning measure appropriated its name, "Newton for Everyone," for a political action committee to fund candidates opposing the plan, violating its trademark rights and other laws.

  • August 07, 2025

    Fed. Circ. Affirms PTAB Ax Of Bone Fusion Device Patents

    The Federal Circuit on Thursday upheld Patent Trial and Appeal Board rulings that invalidated claims in a pair of Stryker Corp. patents for a surgical implant that a Berkshire Hathaway-owned rival had challenged.

  • August 07, 2025

    LIV Golf, Stinger Tees Enter Mediation Over Trademark Clash

    A Florida federal court has appointed a retired state circuit court judge to mediate the trademark infringement dispute between LIV Golf Inc. and the Stinger Tees merchandise company.

  • August 07, 2025

    Cosmetics Co. Says Rival Copied LED Face Mask Style

    A British cosmetics company has told a London court that a French competitor infringed its intellectual property rights in the style of a popular LED light-therapy mask.

  • August 07, 2025

    NC Biz Court Bulletin: Divorce Dust-Ups And Judicial Rebukes

    Litigation in the North Carolina Business Court is heating up this summer with new complaints centered on fears a former state politician's divorce proceedings will impede his companies' operations and accusations that a climate technology company has failed to pay out a former engineer's ownership interest.

  • August 06, 2025

    Baker Botts Atty Seeks To Trim Patent Exec's Defamation Suit

    A Baker Botts LLP intellectual property litigator has urged a Florida federal judge to trim a patent licensing company executive's lawsuit alleging she made defamatory statements about him in news articles, saying some of the claims come too late, and others don't have a basis in facts.

  • August 06, 2025

    USPTO's Stewart Suggests Org. Is Eyeing Patent Fee Changes

    U.S. Patent and Trademark Office acting Director Coke Morgan Stewart addressed rumors that the Trump administration is considering a new fee on the values of patents on Wednesday, saying Commerce Secretary Howard Lutnick is "very concerned" about the "disconnect" between the low costs of obtaining patents and their huge worth.

  • August 06, 2025

    Axed Verdicts Put Spotlight On Patent Applicant Statements

    Recent Federal Circuit decisions overturning substantial patent judgments due to statements the patent owner made during the application process illustrate the importance of applicants carefully calibrating their arguments, particularly when seeking design patents, attorneys say.

  • August 06, 2025

    Bong Maker Warned Of Sanctions After Repeated Errors

    A Texas federal judge said Tuesday he's issued his last warning to a California-based bong maker which has filed nearly five dozen trademark infringement cases against head shops in North Texas, saying sanctions will come if the company keeps making the same procedural mistakes.

  • August 06, 2025

    Judge Says No New Trial In Fleet Monitoring Patent Fight

    A California federal judge said Tuesday there is no basis for a new trial after a jury in April cleared Motive Technologies of allegations that it infringed a series of fleet monitoring patents, but ruled that claims in two of the patents were ineligible for patent protection to begin with.

Expert Analysis

  • Adapting To PTAB's Reembracing Of Discretionary Denials

    Author Photo

    Recent guidance from the U.S. Patent and Trademark Office marks a swing back toward procedural discretion in Patent Trial and Appeal Board trial institution decisions, bringing unpredictability but also opportunities for drafting petitions, and making and responding to discretionary denial arguments, says Taylor Stemler at Merchant & Gould.

  • Crisis Management Lessons From The Parenting Playbook

    Author Photo

    The parenting skills we use to help our kids through challenges — like rehearsing for stressful situations, modeling confidence and taking time to reset our emotions — can also teach us the fundamentals of leading clients through a corporate crisis, say Deborah Solmor at the Wisconsin Alumni Research Foundation and Cara Peterman at Alston & Bird.

  • 4 Ways To Leverage A Jury's Underdog Perceptions

    Author Photo

    Counsel should consider how common factors that speak to their client's size, power, past challenges and alignment with jurors can be presented to try and paint their client as a sympathetic underdog, says Ken Broda-Bahm at Persuasion Strategies.

  • 4 Legislative Proposals Reflect Growing Scrutiny Of Pharma IP

    Author Photo

    Bipartisan legislative momentum in Congress, including a recent package of bills targeting exclusivity strategies that delay generic and biosimilar competition, signals growing scrutiny of life sciences intellectual property strategies, so biologics companies and investors must pay attention to new strategic, compliance and litigation risks, says Olga Berson at Thompson Coburn.

  • Why Hiring Former Jurors As Consultants Can Be Risky

    Author Photo

    The defense team's decision to hire former juror Victoria George in the high-profile retrial of Karen Read shines a spotlight on this controversial strategy, which raises important legal, ethical and tactical questions despite not being explicitly prohibited, says Nikoleta Despodova at ND Litigation.

  • Series

    Adapting To Private Practice: From NY Fed To BigLaw

    Author Photo

    While the move to private practice brings a learning curve, it also brings chances to learn new skills and grow your network, requiring a clear understanding of how your skills can complement and contribute to a firm's existing practice, and where you can add new value, says Meghann Donahue at Covington.

  • What Businesses Need To Know About EU Design Law Reform

    Author Photo

    Recent reforms to European Union design protection law will broaden the scope of what constitutes protected designs and products, likely creating new opportunities and considerations for businesses operating within the EU or those engaging with its markets, say lawyers at Foley & Lardner.

  • Berry Ruling Shows Why Plant IP Suits Can Be Thorny

    Author Photo

    A California federal court's recent decision in Driscoll's v. California Berry Cultivars illustrates that while a path exists for asserting U.S. plant patent rights against extraterritorial breeders, it can be difficult to prove infringement based on importation of plant parts, say Travis Bliss and Stephany Small at Panitch Schwarze.

  • 7 Considerations For Conducting Drug Clinical Trials Abroad

    Author Photo

    With continuing cuts to U.S. Food and Drug Administration staffing motivating some pharmaceutical companies to consider developing drugs abroad, it's important to understand the additional risks and compliance requirements associated with conducting clinical studies in other countries, say attorneys at Morgan Lewis.

  • Top 3 Litigation Finance Deal-Killers, And How To Avoid Them

    Author Photo

    Like all transactions, litigation finance deals can sometimes collapse, but understanding the most common reasons for failure, including a lack of trust or a misunderstanding of deal terms, can help both parties avoid problems, say Rebecca Berrebi at Avenue 33 and Boris Ziser at Schulte Roth.

  • Best Practices For Companies Integrating Existing IP With AI

    Author Photo

    Some copyright owners are exploring how they can make new content by combining their existing intellectual property assets with generative artificial intelligence, and although these initiatives can serve multiple business goals, those considering such practices should be aware they are entering largely uncharted waters, says Josh Weigensberg at Pryor Cashman.

  • How Attys Can Use A Therapy Model To Help Triggered Clients

    Author Photo

    Attorneys can lean on key principles from a psychotherapeutic paradigm known as the "Internal Family Systems" model to help manage triggered clients and get settlement negotiations back on track, says Jennifer Gibbs at Zelle.

  • How Athletes Can Protect Their Signature Celebrations As IP

    Author Photo

    As copyright and trademark law adapts to short-form choreography and dynamic media, athletes and their business partners have new tools to protect the intellectual property embedded in their unique dances, poses and celebrations, say attorneys at Debevoise.

  • Opinion

    Third-Party Funding Transparency Is Key In Patent Suits

    Author Photo

    Third-party litigation funding is a growing industry that could benefit from enhanced disclosure standards to ensure transparency, as challenges in obtaining discovery of such funding can complicate patent litigation against nonpracticing entities, say attorneys at Skadden.

  • How Attorneys Can Make The Most Of A Deposition Transcript

    Author Photo

    With recent amendments to federal evidence rules now in effect, it’s more important than ever to make sure that deposition transcripts are clear and precise, and a few key strategies can help attorneys get the most out of a transcript before, during and after a deposition, says Allison Rocker at Baker McKenzie.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.